相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。TLR Agonists as Vaccine Adjuvants Targeting Cancer and Infectious Diseases
Marina Luchner et al.
PHARMACEUTICS (2021)
KISIMA-01 trial: Safety, tolerability and immunogenicity of ATP128 with or without ezabenlimab (BI 754091) in patients with stage IV colorectal cancer - preliminary results from a phase 1b study
S. Kopetz et al.
ANNALS OF ONCOLOGY (2021)
The CD83 Molecule - An Important Immune Checkpoint
Linda Grosche et al.
FRONTIERS IN IMMUNOLOGY (2020)
Cell-Penetrating Peptides: Efficient Vectors for Vaccine Delivery
Jieru Yang et al.
CURRENT DRUG DELIVERY (2019)
Toll-like receptor 2?dependent endosomal signaling by Staphylococcus aureus in monocytes induces type I interferon and promotes intracellular survival
Jana Musilova et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2019)
Targeting self- and neoepitopes with a modular self-adjuvanting cancer vaccine
Elodie Belnoue et al.
JCI INSIGHT (2019)
Correlates of adjuvanticity: A review on adjuvants in licensed vaccines
Giuseppe Del Giudice et al.
SEMINARS IN IMMUNOLOGY (2018)
Combinatorial Delivery of Dual and Triple TLR Agonists via Polymeric Pathogen-like Particles Synergistically Enhances Innate and Adaptive Immune Responses
Ranjna Madan-Lala et al.
SCIENTIFIC REPORTS (2017)
Significant role for IRF3 in both T cell and APC effector functions during T cell responses
Zacharey Guinn et al.
CELLULAR IMMUNOLOGY (2016)
Monomeric annexin A2 is an oxygen regulated toll-like receptor 2 ligand and adjuvant
Brian M. Andersen et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2016)
Novel Cell-Penetrating Peptide-Based Vaccine Induces Robust CD4+ and CD8+ T Cell-Mediated Antitumor Immunity
Madiha Derouazi et al.
CANCER RESEARCH (2015)
The Architecture of the TIR Domain Signalosome in the Toll-like Receptor-4 Signaling Pathway
Emine Guven-Maiorov et al.
SCIENTIFIC REPORTS (2015)
Co-operation of TLR4 and raft proteins in LPS-induced pro-inflammatory signaling
Agnieszka Plociennikowska et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2015)
Toll-Like Receptor 11-Initiated Innate Immune Response in Male Mouse Germ Cells
Qiaoyuan Chen et al.
BIOLOGY OF REPRODUCTION (2014)
T cell-intrinsic role of IL-6 signaling in primary and memory responses
Simone A. Nish et al.
ELIFE (2014)
Evolving bacterial envelopes and plasticity of TLR2-dependent responses: basic research and translational opportunities
Junbin Li et al.
FRONTIERS IN IMMUNOLOGY (2013)
Role of CLIC4 in the host innate responses to bacterial lipopolysaccharide
Guoan He et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2011)
Annexin A2 tetramer activates human and murine macrophages through TLR4
Jennifer F. A. Swisher et al.
BLOOD (2010)
Characterization of the Cell-penetrating Properties of the Epstein-Barr Virus ZEBRA trans-Activator
Romy Rothe et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
Antigen presentation by dendritic cells in vivo
Elodie Segura et al.
CURRENT OPINION IN IMMUNOLOGY (2009)
AS04, an Aluminum Salt- and TLR4 Agonist-Based Adjuvant System, Induces a Transient Localized Innate Immune Response Leading to Enhanced Adaptive Immunity
Arnaud M. Didierlaurent et al.
JOURNAL OF IMMUNOLOGY (2009)
Activating immunity: lessons from the TLRs and NLRs
Tom P. Monie et al.
TRENDS IN BIOCHEMICAL SCIENCES (2009)
Signaling to NF-κB by Toll-like receptors
Taro Kawai et al.
TRENDS IN MOLECULAR MEDICINE (2007)
Enhancement of human melanoma antigen expression by IFN-β
Ian S. Dunn et al.
JOURNAL OF IMMUNOLOGY (2007)
Synergism of Toll-like receptor-induced interleukin-12p70 secretion by monocyte-derived dendritic cells is mediated through p38 MAPK and lowers the threshold of T-helper cell type I responses
Hermann R. Bohnenkamp et al.
CELLULAR IMMUNOLOGY (2007)
The family of five: TIR-domain-containing adaptors in Toll-like receptor signalling
Luke A. J. O'Neill et al.
NATURE REVIEWS IMMUNOLOGY (2007)
MyD88-dependent and MyD88-independent pathways in synergy, priming, and tolerance between TLR agonists
Aranya Bagchi et al.
JOURNAL OF IMMUNOLOGY (2007)
Synergistic activation of dendritic cells by combined Toll-like receptor ligation induces superior CTL responses in vivo
Tobias Warger et al.
BLOOD (2006)
TLR signaling
T Kawai et al.
CELL DEATH AND DIFFERENTIATION (2006)
A novel cyclohexene derivative, ethyl (6R)-6-[N-(2-chloro-4-fluorophenyl) sulfamoyl]cyclohex-1-ene-1-carboxylate (TAK-242), selectively inhibits toll-like receptor 4-mediated cytokine production through suppression of intracellular signaling
M Ii et al.
MOLECULAR PHARMACOLOGY (2006)
Selected Toll-like receptor agonist combinations synergistically trigger a T helper type 1-polarizing program in dendritic cells
G Napolitani et al.
NATURE IMMUNOLOGY (2005)
Differential expression regulation of the α and β subunits of the PA28 proteasome activator in mature dendritic cells
F Ossendorp et al.
JOURNAL OF IMMUNOLOGY (2005)
Toll-like receptors in innate immunity
K Takeda et al.
INTERNATIONAL IMMUNOLOGY (2005)
Lipopolysaccharide stimulates the MyD88-independent pathway and results in activation of IFN-regulatory factor 3 and the expression of a subset of lipopolysaccharide-inducible genes
T Kawai et al.
JOURNAL OF IMMUNOLOGY (2001)